We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
3751
DELISTED
Applied Genetic Technologies Corporation
AGTC
$127K ﹤0.01%
118,840
+30,000
+34% +$54.5K
AMBO
3752
Ambow Education Holding
AMBO
$5.66M
$126K ﹤0.01%
16,412
+160
+1% +$1.21K
CASI
3753
DELISTED
CASI Pharmaceuticals
CASI
$126K ﹤0.01%
15,530
-130,277
-89% -$1.02M
SXTC icon
3754
China SXT Pharmaceuticals
SXTC
$2.36M
$126K ﹤0.01%
+1
New +$155K
AXLA
3755
DELISTED
Axcella Health Inc. Common Stock
AXLA
$126K ﹤0.01%
1,956
+92
+5% +$4.59K
FRMM
3756
Forum Markets
FRMM
$68.2M
$125K ﹤0.01%
+13
New +$149K
NURO
3757
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$125K ﹤0.01%
3,766
-14,326
-79% -$510K
ASC icon
3758
Ardmore Shipping
ASC
$710M
$124K ﹤0.01%
27,500
+9,000
+49% +$35.3K
SYBX
3759
DELISTED
Synlogic
SYBX
$123K ﹤0.01%
3,420
-227
-6% -$7.07K
JNCE
3760
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$123K ﹤0.01%
+18,100
New +$129K
FINV
3761
FinVolution Group
FINV
$1.15B
$121K ﹤0.01%
+30,500
New +$127K
SANW
3762
DELISTED
S&W Seed Co
SANW
$121K ﹤0.01%
2,980
-963
-24% -$42.2K
USAS
3763
Americas Gold and Silver
USAS
$1.29B
$121K ﹤0.01%
+44,840
New +$107K
NABL icon
3764
N-able
NABL
$882M
$120K ﹤0.01%
+13,200
New +$139K
WKEY
3765
WISeKey
WKEY
$70.3M
$119K ﹤0.01%
9,300
+5,600
+151% +$91.4K
PHAS
3766
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$118K ﹤0.01%
+89,300
New +$145K
CDAK
3767
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$116K ﹤0.01%
+18,500
New +$116K
BLRX
3768
BioLineRX
BLRX
$12.3M
$115K ﹤0.01%
1,684
+1,331
+377% +$92.7K
VIOT
3769
Viomi Technology
VIOT
$51.8M
$115K ﹤0.01%
65,864
+22,100
+50% +$43K
MYSZ icon
3770
My Size
MYSZ
$1.98M
$114K ﹤0.01%
1,647
-892
-35% -$67.7K
OXBR icon
3771
Oxbridge Re Holdings
OXBR
$10.6M
$114K ﹤0.01%
20,882
-9,118
-30% -$52K
MEC icon
3772
Mayville Engineering Co
MEC
$654M
$113K ﹤0.01%
12,100
-23,500
-66% -$267K
PAVS icon
3773
Paranovus Entertainment Technology
PAVS
$4.13M
0
TRDA icon
3774
Entrada Therapeutics
TRDA
$264M
$111K ﹤0.01%
11,800
-1,773
-13% -$19K
IMG
3775
DELISTED
CIMG Inc
IMG
$111K ﹤0.01%
+72
New +$127K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.